FracRevive®
Skin Rejuvenation and Tone Improvement
- Improves spots and wrinkles
- Reduces pore size
- Improves skin texture and tone
- High patient satisfaction
- Minimally invasive
- Minimal downtime
- Comfortable and fast treatment
- Easy to perform
What is FracRevive®?
FracRevive® is an efficient two-step skin rejuvenation treatment with minimal downtime, performed with both full-beam and fractional Q-switched Nd:YAG laser. The treatment improves the patient’s skin tone and texture as well as reduces pore size, pigmentation, and static wrinkles.
How Does it Work?
Step 1
In the first step, three to four passes of full-beam MaQX-1 Nd:YAG are applied utilizing a quick brushing method to cover the entire face.
Step 2
Minimally ablative FracTAT® technology is used in step 2. Two passes are performed to cover the entire face, with an additional two passes applied on areas with more pronounced problems such as large pores, pigmentation, and uneven skin tone. The treatment can be repeated after four to six weeks.
High Patient Satisfaction
Improved skin tone and texture can be observed already after just one treatment, while four sessions are recommended for optimal results. Once the desirable improvement is achieved, the treatment can be repeated every three to four months as a maintenance therapy. Patients report high satisfaction with the procedure and great improvement in skin complexion.
FracTAT®
Fotona’s innovative FracTAT® technology, based on high-energy pulses of fractional Q-switched Nd:YAG laser, enables extremely high peak powers to be concentrated in a matrix of tiny spots to induce fractional photoacoustic shockwaves. When the FracTAT® procedure is performed in non-ablative mode, fractional microscopic lesions are formed in the epidermis and dermis due to plasma micro-explosions, leading to cavitation, while the tissue surface remains intact.
The FracTAT® mode is ideal for applications such as rejuvenation, texture improvement and acne scar revision, particularly in darker skin types for which other ablative procedures are often avoided.
Products
Clinical Results